Results 151 to 160 of about 15,585 (162)

Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients with ST-Segment–Elevation Myocardial Infarction

Circulation: Cardiovascular Interventions, 2012
Periklis Davlouros, Grigorios Tsigkas, George Kassimis   +2 more
exaly  

Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromes

International Journal of Cardiology, 2011
Giuseppe Sangiorgi, Giuseppe Biondi-Zoccai, Dominick Angiolillo   +2 more
exaly  

Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

Circulation, 2016
Dominick Angiolillo, Francesco Franchi, Fabiana Rollini   +2 more
exaly  

Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease

Circulation, 2017
William Hiatt, Jeffrey Berger
exaly  

Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management

Circulation, 2019
Sung Yun Lee, Jei Keon Chae, Duk-Woo Park   +2 more
exaly  

Association of Proton Pump Inhibitor Use on Cardiovascular Outcomes With Clopidogrel and Ticagrelor

Circulation, 2012
Shaun Goodman, Dominick Angiolillo, Robert Storey   +2 more
exaly  

Adenosine-Mediated Effects of Ticagrelor

Journal of the American College of Cardiology, 2014
Rainer Schulz, Marco Cattaneo
exaly  

Ticagrelor: The First Reversibly Binding Oral P2Y12 Receptor Antagonist

Cardiovascular Therapeutics, 2009
J J J Van Giezen
exaly  

Ticagrelor

Reactions Weekly, 2014
openaire   +1 more source

Premature Ticagrelor Discontinuation in Secondary Prevention of Atherosclerotic CVD

Journal of the American College of Cardiology, 2019
Kamal Shemisa, Sameer Arora, Sandeep Das   +2 more
exaly